KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutrien (NTR) Common Equity (2016 - 2025)

Nutrien has reported Common Equity over the past 10 years, most recently at $25.3 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 3.6% year-over-year to $25.3 billion; the TTM value through Dec 2025 reached $25.3 billion, up 3.6%, while the annual FY2025 figure was $25.3 billion, 3.6% up from the prior year.
  • Common Equity for Q4 2025 was $25.3 billion at Nutrien, up from $24.4 billion in the prior quarter.
  • Over five years, Common Equity peaked at $25.9 billion in Q4 2022 and troughed at $23.7 billion in Q4 2021.
  • A 5-year average of $24.9 billion and a median of $25.2 billion in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: rose 9.13% in 2022 and later decreased 3.01% in 2024.
  • Year by year, Common Equity stood at $23.7 billion in 2021, then increased by 9.13% to $25.9 billion in 2022, then dropped by 2.56% to $25.2 billion in 2023, then dropped by 3.01% to $24.4 billion in 2024, then increased by 3.6% to $25.3 billion in 2025.
  • Business Quant data shows Common Equity for NTR at $25.3 billion in Q4 2025, $24.4 billion in Q4 2024, and $25.2 billion in Q4 2023.